ESCAPE pain trial - The effects of Curcumin in pain relief in women diagnosed with primary dysmenorrhea: A triple blinded, placebo-controlled, phase II, randomized clinical trial protocol

التفاصيل البيبلوغرافية
العنوان: ESCAPE pain trial - The effects of Curcumin in pain relief in women diagnosed with primary dysmenorrhea: A triple blinded, placebo-controlled, phase II, randomized clinical trial protocol
المؤلفون: Daniel Carvajal-Hausdorf, Ana Luisa Soares Neves, Diego Greatti Vaz da Silva, Alberto Durán-Peña, Eladio Radhames Perez Antonio, Pedro Oliveira, Camelia Tang Qian Ying, Danielli Matsuura, Gustavo Costa Nascimento de Carvalho, Tatiana Nayara Libório-Kimura, Mariane Schäffer Castro, Sachin Thigale, Matteo Guidetti, Vahid Nouri Kandany, Bruno Soares Rocha Calabria, Marianne Zelniker, Susan Benedict Navia, Ahmed Abdallah Ahmed Abdallah, Cassiano Ricardo de Oliveira Berto, Elly Pichardo, Edson Santos Ferreira Filho, Ana Isabel Sanchez-Barbero, Arturo Tamayo, Kamran Mushtaq, Denise Saretta Schwartz, Lucas Augusto Pepe Mena, Maria del Pilar Estrella Caballero, Carlos Augusto Rossetti, Khalid Al-Karbi, Ahmed Doomi, Eduardo Dytz Almeida, Gustavo de Almeida, Clarissa Medeiros
المصدر: Principles and Practice of Clinical Research Journal. 6:25-32
بيانات النشر: Principles and Practice of Clinical Research, 2020.
سنة النشر: 2020
مصطلحات موضوعية: medicine.medical_specialty, business.industry, Visual analogue scale, Analgesic, Placebo, law.invention, chemistry.chemical_compound, Superiority Trial, Tolerability, chemistry, Randomized controlled trial, law, Internal medicine, medicine, Curcumin, Adverse effect, business
الوصف: Introduction: Primary dysmenorrhea affects many women, being a major cause of absenteeism and reduced productivity at work and at school. Although non-steroidal anti-inflammatory drugs (NSAIDs) are a good treatment option, up to 18% of women show no response or present allergic reactions and adverse events. Curcumin has antispasmodic, antinociceptive, and both specific and nonspecific anti-inflammatory effects, with good tolerability and safety. To date, no previous trial involving curcumin and dysmenorrhea pain has been performed. Therefore, our main goal is to assess the efficacy of curcumin for pain relief among women with primary dysmenorrhea, along with determining curcumin’s adverse effects and tolerability profile.Methods: A phase II, single-center, randomized, triple-blinded, placebo-controlled, parallel-group, superiority trial to evaluate the effect of curcumin (500 mg/12h) in pain reduction in women (18 to 35-year-old) with primary dysmenorrhea. A first cycle will be used for a passive, observational run-in phase. A sample of 108 participants (54 per group) is necessary to detect a 30% difference in pain sensitivity between groups assessed by visual analogue scale (VAS). Secondary outcomes include side effects, Cox Menstrual Symptom Scale (CMSS), and use of rescue drugs for pain relief. Discussion: Clinical evidence has shown analgesic and anti-inflammatory effects of curcumin and in view of dysmenorrhea’s physiopathology being related to those mechanisms targeted by curcumin, we hypothesize its use could represent an innovative and effective therapy to reduce the severity of this disease and its symptoms. Keywords: primary dysmenorrhea, Curcumin, pain relief, Visual Analogue Scale, Cox Menstrual Symptom Scale.
تدمد: 2378-1890
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::8ab2e43ec22ecad87baa7b85afac9b6a
https://doi.org/10.21801/ppcrj.2020.62.5
حقوق: OPEN
رقم الأكسشن: edsair.doi...........8ab2e43ec22ecad87baa7b85afac9b6a
قاعدة البيانات: OpenAIRE